In cancer, TGFβ signaling often presents the dichotomy of a “double-edged sword” [9], inhibiting proliferation in early stages [10], while promoting invasiveness and metastasis formation in later stages of tumor progression [11, 12]. The gene discussed is TGFB1; the disease is neoplasm.